From multiplex serology to serolomics – a novel approach to the antibody response against the SARS-CoV-2 proteome
Julia Butt, Rajagopal Murugan, Theresa Hippchen, Sylvia Olberg, Monique van Straaten, Hedda Wardemann, Erec Stebbins, Hans-Georg Kräusslich, Ralf Bartenschlager, Hermann Brenner, Vibor Laketa, Ben Schöttker, Barbara Müller, Uta Merle, Tim Waterboer
doi: https://doi.org/10.1101/2020.10.19.20214916
Julia Butt
1Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
Rajagopal Murugan
2B Cell Immunology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
Theresa Hippchen
3Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany
Sylvia Olberg
4Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany
5German Center for Infection Research (DZIF), Heidelberg partner site, Heidelberg, Germany
Monique van Straaten
6Division of Structural Biology of Infection and Immunity, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
Hedda Wardemann
2B Cell Immunology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
Erec Stebbins
6Division of Structural Biology of Infection and Immunity, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
Hans-Georg Kräusslich
4Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany
5German Center for Infection Research (DZIF), Heidelberg partner site, Heidelberg, Germany
Ralf Bartenschlager
5German Center for Infection Research (DZIF), Heidelberg partner site, Heidelberg, Germany
7Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany
8Division Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany
Hermann Brenner
9Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
10Network Aging Research, University of Heidelberg, Heidelberg, Germany
Vibor Laketa
4Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany
5German Center for Infection Research (DZIF), Heidelberg partner site, Heidelberg, Germany
Ben Schöttker
9Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
10Network Aging Research, University of Heidelberg, Heidelberg, Germany
Barbara Müller
4Department of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany
Uta Merle
3Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany
Tim Waterboer
1Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany
Data Availability
All summary data generated or analyzed during this study are included in this published article and its supplementary material file. The primary data are available from the corresponding author on reasonable request.
Posted October 21, 2020.
From multiplex serology to serolomics – a novel approach to the antibody response against the SARS-CoV-2 proteome
Julia Butt, Rajagopal Murugan, Theresa Hippchen, Sylvia Olberg, Monique van Straaten, Hedda Wardemann, Erec Stebbins, Hans-Georg Kräusslich, Ralf Bartenschlager, Hermann Brenner, Vibor Laketa, Ben Schöttker, Barbara Müller, Uta Merle, Tim Waterboer
medRxiv 2020.10.19.20214916; doi: https://doi.org/10.1101/2020.10.19.20214916
From multiplex serology to serolomics – a novel approach to the antibody response against the SARS-CoV-2 proteome
Julia Butt, Rajagopal Murugan, Theresa Hippchen, Sylvia Olberg, Monique van Straaten, Hedda Wardemann, Erec Stebbins, Hans-Georg Kräusslich, Ralf Bartenschlager, Hermann Brenner, Vibor Laketa, Ben Schöttker, Barbara Müller, Uta Merle, Tim Waterboer
medRxiv 2020.10.19.20214916; doi: https://doi.org/10.1101/2020.10.19.20214916
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2876)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12600)
- Forensic Medicine (10)
- Gastroenterology (810)
- Genetic and Genomic Medicine (4473)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4231)
- Nursing (226)
- Nutrition (619)
- Oncology (2217)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)